Establishing a Market Leader: Building TGaS Advisors’ Reputation in Pharmaceutical Operations
TGaS Advisors, acquired by Trinity in 2018, is a benchmarking and advisory services firm that entered the pharmaceutical sector with a unique collaborative model designed to empower organizations through shared operational insights and best practices. To differentiate the company in a highly competitive marketplace and position it as an industry leader, TGaS engaged Rosica Communications, a leading thought leadership PR agency, to develop and execute a comprehensive thought leadership and reputation-building strategy.
The challenge was to effectively communicate TGaS’s distinctive mission to pharmaceutical executives, establish credibility, and elevate the brand’s visibility among key stakeholders and decision-makers.
Rosica implemented a strategic, multi-faceted communications plan that included leveraging TGaS’s positioning through top-tier industry trade media, developing high-level thought leadership content, securing prominent speaking engagements for firm principals, and nominating the company for prestigious industry awards. Each initiative was carefully designed to reinforce TGaS’s leadership and expertise in pharmaceutical operations.
Rosica secured consistent coverage for the company in leading pharmaceutical industry publications and facilitated multiple speaking opportunities at high-profile conferences. The firm earned national recognition from Inc. 500, Philadelphia 100, the American Business Awards, and PharmaVOICE. These efforts contributed to more than 50% revenue growth, a doubling of TGaS’s employee base, and a 75% increase in client acquisition in just 12 months.
Through strategic positioning, targeted media outreach, and thought leadership development, Rosica Communications, a national healthcare PR agency, helped establish TGaS Advisors as a trusted authority in pharmaceutical advisory services, accelerating the firm’s growth and solidifying its reputation in the industry.
